Cited by 107Epilepsy research and treatmentLong-Term Effects of COVID-19Infectious Encephalopathies and Encephalitis

Epilepsy and COVID-19: Associations and important considerations

Open access
Kuroda, Naoto·2020·Epilepsy & Behavior

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.yebeh.2020.107122

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Patients with epilepsy have less access to medical care due to collapse of healthcare services.

    “they have less access to medical care due to collapse of the healthcare services [44–46]”

    From The Psychological Flexibility in Epilepsy Questionnaire (PFEQ): Psychometric properties of the Persian version (2022) · cites this paper as [45]

    The Introduction section on maintaining seizure control says infectious-disease outbreaks can prevent patients with epilepsy from keeping routine appointments. The section on monitoring units and surgery says elective procedures may be postponed. These passages support potential disruption of care, but neither attributes reduced access to a collapse of healthcare services; page numbers are unavailable in our copy. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Patients with epilepsy may be a high-risk group for developing more severe COVID-19 symptoms.

    “they may be high-risk group for developing more severe symptoms with COVID-19”

    From The Psychological Flexibility in Epilepsy Questionnaire (PFEQ): Psychometric properties of the Persian version (2022) · cites this paper as [45]

    In the Introduction section on COVID-19 risk (page not provided), Kuroda reports that the CDC suggested epilepsy might be a risk factor, while emphasizing the lack of evidence and noting that epilepsy itself seemed unlikely to increase risk of developing COVID-19. The section on COVID-19’s effects says those effects in patients with epilepsy remain unclear. Neither passage establishes that patients with epilepsy are at higher risk of more severe symptoms; the claim conflates risk of infection with severity. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • Pandemic-related restrictions create an additional social and psychological burden for patients with epilepsy.

    “pandemic-related restrictions create an additional social and psychological burden for patients with epilepsy”

    From The Psychological Flexibility in Epilepsy Questionnaire (PFEQ): Psychometric properties of the Persian version (2022) · cites this paper as [45]

    The ‘Considerations for caregivers or patients who live alone’ section describes isolation, interrupted caregiver support, and the need for contact while self-isolating. ‘Importance of spreading awareness’ discusses anxiety and stress, but attributes them to information and misinformation rather than pandemic-related restrictions. The paper therefore supports social disruption and psychological concerns, but not the claimed link between restrictions and both burdens. (LLM, conf=0.79)

    Experimental — accuracy not yet measured
  • The COVID-19 pandemic has been an additional challenge for patients with epilepsy.

    “Studies targeting patients with epilepsy during the COVID-19 pandemic show that the COVID-19 pandemic has been an additional challenge for those who suffer from epilepsy”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 22 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Kuroda, N.
Affiliations
Wayne State University (US)
Corresponding author
Kuroda, Naoto
Venue
Epilepsy & Behavior
Publisher
Elsevier BV
Published
2020-07
Volume
108
Pages
107122
ISSN
1525-5050 (ISSN-L)
OpenAlex
W3020417150
Cited by
107
References
22
Citations by year
2025: 1 · 2024: 8 · 2023: 11 · 2022: 15 · 2021: 29 · 2020: 43
FWCI
17.88
Type
journal article
Language
en
Open access
Locations
  • Epilepsy & Behavior (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Epilepsy research and treatment
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
  • Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
Keywords
epilepsy, COVID-19 pandemic, SARS-CoV-2, antiepileptic drug safety, seizure risk, lockdown measures

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review